Role of AI in CE for the Identification of SB Lesions in Patients With Small Intestinal Bleeding.
ArtIC
Role of the Artificial Intelligence in Capsule Endoscopy for the Identification of Small Bowel Lesions in Patients With Small Intestinal Bleeding ArtIC Study: Artificial Intelligence Capsule Endoscopy Study
1 other identifier
interventional
137
1 country
1
Brief Summary
Capsule Endoscopy (CE) is a safe, patient friendly and easy procedure performed for the evaluation of gastrointestinal tract unable to be explored via conventional endoscopy. The most common indication to perform SBCE is represented by Suspected Small Bowel Bleeding (SSBB). According to the widest meta-analysis available in literature, SBCE shows a diagnostic yield in SSBB of about 60%, and angiodysplasias are the most relevant findings, accounting for 50% of patients undergoing SBCE for SSBB. Accordingly, it represents the first line examination in SSBB investigation for determining the source of bleeding, if primary endoscopy results negative. Despite its high clinical feasibility, the evaluation of CE-video-captures is one of the main drawbacks since it is time consuming and requests the reader to concentrate to not miss any lesion. In order to reduce reading time, several software have been developed with the aim to cut similar images and select relevant images. For example, automated fast reading software have demonstrated to significantly reduce reading time without impacting the miss rate in pathological conditions affecting diffusely the mucosa (as IBD lesions do). Not the same assumption can be taken for isolated lesions since several studies reported an unacceptable miss rate for such a detection modality. New advancements such as artificial intelligence made their appearance in recent years. Deep convolutional neural networks (CNNs) have demonstrated to recognize specific images among a large variety up to exceed human performance in visual tasks. A Deep Learning model has been recently validated in the field of Small Bowel CE by Ding et al. According to their data collected on 5000 patients, the CNN-based auxiliary model identify abnormalities with 99.88% sensitivity in the per patient analysis and 99.90% sensitivity in the per-lesion analysis. With this perspective, it is believable that AI applied to SBCE can significantly shorten the reading time and support physicians to detect available lesions without losing significant lesions, further improving the diagnostic yield of the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2021
CompletedFirst Submitted
Initial submission to the registry
March 12, 2021
CompletedFirst Posted
Study publicly available on registry
March 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedFebruary 21, 2024
November 1, 2022
1.2 years
March 12, 2021
February 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy of AI-assisted video reading versus traditional video reading with conventional software.
sensitivity, specificity, PPV, NPV calculated at per-patient analysis for P1 / P2 lesions, compared with the adjudication committee as gold standard in case of discrepancies.
through study completion, an average of 1 year
Secondary Outcomes (6)
evaluation of Reading time of AI-assisted reading compared with conventional reading
through study completion, an average of 1 year
Role of AI-assisted reading in real life from a health economic perspective
through study completion, an average of 1 year
Accuracy of AI-assisted video reading versus traditional video reading with conventional software.
through study completion, an average of 1 year
Accuracy of AI-assisted video reading versus traditional video reading with conventional software considering any lesions for a per-patient analysis with the adjudication committee as gold standard in case of discrepancies.
through study completion, an average of 1 year
Diagnostic yield of CE
through study completion, an average of 1 year
- +1 more secondary outcomes
Study Arms (1)
Single arm study
OTHERStandard reading Group vs AI-assisted reading Group
Interventions
A consecutive series of patients recruited by 12 European centers based on the indication of OGIB will undergo capsule endoscopy examination. Capsule endoscopy will be performed in each site according to local rules and requirements, and the study protocol will concern only the post-procedure analysis on reading modalities for each patient.
Eligibility Criteria
You may qualify if:
- indication of OGIB:1)after negative upper and lower endoscopy; 2)France: after negative pregnancy test; 3)Hb cut-off male: \<13, female: \<12
You may not qualify if:
- Age \< 18 years old
- Known or suspected intestinal obstruction
- Non-steroidal anti-inflammatory drugs (twice weekly or more) during the 4 weeks preceding enrollment
- Patient is expected to undergo MRI examination within 7 days after ingestion of the capsule
- Patient with known gastrointestinal motility disorders
- Subjects with known or suspected delayed gastric emptying
- Patient suffers from any condition, such as swallowing problems, which precludes compliance with study and/or device instructions
- Patient has any allergy or other known contraindication or intolerance to the medications used in the study
- Patient has any condition, which precludes compliance with study and/or device instructions
- Patient with any contraindication to take the bowel preparation product
- Women who are either pregnant or nursing at the time of screening, or are of child- bearing potential and do not practice medically acceptable methods of contraception
- Concurrent participation in another clinical trial using any investigational drug or device
- Patient suffers from a life-threatening condition
- Patients with history or clinical evidence of renal disease and/or previous clinically significant laboratory abnormalities of renal function parameters
- Patients with pace-maker or implantable cardioverter
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione Poliambulanza Istituto Ospedalierolead
- Humanitas Hospital, Italycollaborator
- Fondazione Policlinico Universitario Agostino Gemelli IRCCScollaborator
- Skane University Hospitalcollaborator
- Hospital Clinic of Barcelonacollaborator
- Universitätsklinikum Hamburg-Eppendorfcollaborator
- Sheffield Teaching Hospitals NHS Foundation Trustcollaborator
- Endo-Kapszula Magánorvosi Centrumcollaborator
- Szeged Universitycollaborator
- Saint Antoine University Hospitalcollaborator
- Hospital Avicennecollaborator
- South Tyneside and Sunderland NHS Foundation Trustcollaborator
- Northwick Park Hospitalcollaborator
- Hospices Civils de Lyoncollaborator
- Royal Free Hospital NHS Foundation Trustcollaborator
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator
Study Sites (1)
Fondazione Poliambulanza
Brescia, 25124, Italy
Related Publications (1)
Spada C, Piccirelli S, Hassan C, Ferrari C, Toth E, Gonzalez-Suarez B, Keuchel M, McAlindon M, Finta A, Rosztoczy A, Dray X, Salvi D, Riccioni ME, Benamouzig R, Chattree A, Humphries A, Saurin JC, Despott EJ, Murino A, Johansson GW, Giordano A, Baltes P, Sidhu R, Szalai M, Helle K, Nemeth A, Nowak T, Lin R, Costamagna G. AI-assisted capsule endoscopy reading in suspected small bowel bleeding: a multicentre prospective study. Lancet Digit Health. 2024 May;6(5):e345-e353. doi: 10.1016/S2589-7500(24)00048-7.
PMID: 38670743DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Each center will receive from another center anonymized patient videos that have been uploaded on an encrypted USB key. Indeed, expert gastroenterologists from each center will proceed with AI-assisted video reading without knowing which center the video comes from nor the results of the normal reading. Reading conditions are the same as for standard reading. Results from both normal and AI-assisted reading will be compared. In the case of significant disagreement between the results from conventional capsule endoscopy reading and AI-assisted reading (e.g. missed lesions), a consensus review for each center will be done. Any lesion shall be considered.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2021
First Posted
March 29, 2021
Study Start
February 16, 2021
Primary Completion
May 5, 2022
Study Completion
October 1, 2022
Last Updated
February 21, 2024
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
All data and source code can be made available after the manuscript publication on reasonable request, which must include an appropriate protocol, analysis plan, and data exchange with institutional approvals in place before data transfer of any information.